Evidence map›Paper›PMID 36212986›Full record

ArticleBioinorganic chemistry and applications2022

Structural, Optical, Antibacterial, and Anticancer Properties of Cerium Oxide Nanoparticles Prepared by Green Synthesis Using

Abozer Y Elderdery, Badr Alzahrani, Abdulrahim A Alabdulsalam, Siddiqa M A Hamza, Ahmed M E Elkhalifa, Abdulaziz H Alhamidi, Fehaid Alanazi, A Mohamedain, Suresh Kumar Subbiah, Pooi Ling Mok

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinorganic chemistry and applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Pluronic-F-127-Passivated SnOPlants (Basel, Switzerland) · 2023
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 4 countries.

Abozer Y ElderderyDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID https://orcid.org/0000-0002-6219-5312
Badr AlzahraniDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
Abdulrahim A AlabdulsalamDepartment of Biomedical Sciences, College of Medicine, King Faisal University, Hofuf, Saudi Arabia.
Siddiqa M A HamzaCollege of Medicine, Department of Pathology, Umm Al-Qura University Algunfuda, Mecca, Saudi Arabia.
Ahmed M E ElkhalifaDepartment of Public Health, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-2660-5054
Abdulaziz H AlhamidiClinical Laboratory Sciences Department, College of Applied Medical Science, King Saud University, Riyadh, Saudi Arabia.
Fehaid AlanaziDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences-Al-qurayyat, Jouf University, Sakaka, Saudi Arabia.
A MohamedainDepartment of Biomedical Sciences, College of Medicine, King Faisal University, Hofuf, Saudi Arabia.
Suresh Kumar SubbiahCentre for Materials Engineering and Regenerative Medicine, Bharath Institute of Higher Education and Research, Chennai, India.ORCID https://orcid.org/0000-0002-0505-7554
Pooi Ling MokDepartment of Biomedical Science, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Seri Kembangan, Selangor, Malaysia.ORCID https://orcid.org/0000-0001-9688-0716
Jouf University · SABharath University · INKing Faisal University · SAKing Saud University · SASaudi Electronic University · SAUmm al-Qura University · SAUniversiti Putra Malaysia · MYUniversity of Khartoum · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, new advancements in the area of nanotechnology opened up new prospects in the field of medicine that could provide us with a solution for numerous medical complications. Although a several varieties of nanoparticles is being explored to be used as nanomedicines, cerium oxide nanoparticles (CeO

Identifiers

PMID36212986
PMCPMC9534709
OpenAlexW4297516493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.